Drawing for TETRAVIV

USPTO serial 88671680

TETRAVIV

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
PINO, BRIAN
Law office
PETITIONS OFFICE

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with TETRAVIV?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Marlo Hittman

354 EISENHOWER PARKWAY, PLAZA ILIVINGSTON, NJ 07039UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Topical gel for medical and therapeutic treatment of wounds including those such as cold soresACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Dec 19, 2022MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 19, 2022ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Aug 11, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Aug 10, 2022EX4GSOU EXTENSION 4 GRANTED—
Jul 12, 2022NREVNOTICE OF REVIVAL - E-MAILED—
Jul 12, 2022PGEXPETITION GRANTED - EXTENSION REQUEST FILED—
Jul 7, 2022ERTPTEAS RESPONSE TO PETITION DEFICIENCY RECEIVED—
Jun 8, 2022PINMINCOMPLETE PETITION NOTICE MAILED—
Jun 6, 2022APETASSIGNED TO PETITION STAFF—
May 12, 2022EXT4SOU EXTENSION 4 FILED—
May 11, 2022EX3GSOU EXTENSION 3 GRANTED—
May 2, 2022PETRPETITION TO REVIVE-RECEIVED—
May 2, 2022TPDRTEAS PETITION TO DIRECTOR RECEIVED—
Dec 13, 2021MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 13, 2021ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 11, 2021EXT3SOU EXTENSION 3 FILED—
Jul 29, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jul 28, 2021EX2GSOU EXTENSION 2 GRANTED—
Jun 30, 2021NREVNOTICE OF REVIVAL - E-MAILED—
Jun 29, 2021TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION—
Jun 29, 2021PETGPETITION TO REVIVE-GRANTED—
Jun 29, 2021PROATEAS PETITION TO REVIVE RECEIVED—
Jun 14, 2021MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jun 14, 2021ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
May 12, 2021EXT2SOU EXTENSION 2 FILED—
Mar 19, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Mar 18, 2021EX1GSOU EXTENSION 1 GRANTED—
Mar 15, 2021AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Dec 17, 2020NREVNOTICE OF REVIVAL - E-MAILED—
Dec 16, 2020TPEXSOU EXTENSION RECEIVED WITH TEAS PETITION—
Dec 16, 2020PETGPETITION TO REVIVE-GRANTED—
Dec 16, 2020PROATEAS PETITION TO REVIVE RECEIVED—
Dec 14, 2020MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 14, 2020ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 12, 2020EXT1SOU EXTENSION 1 FILED—
May 12, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 17, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 17, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 26, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 10, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 4, 2020DOCKASSIGNED TO EXAMINER—
Nov 1, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Nov 1, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance